Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Evaluating XPERIENCE™ Advanced Surgical Irrigation

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Ottawa Hospital Research Institute
Azonosító
NCT05543941
A regiszteradat frissítve
2026. május 28.
Eredeti leírás
A prospective, multi-center, double-arm, parallel, interventional, randomized, controlled clinical trial to assess the rate of periprosthetic joint infection (PJI) in patients undergoing primary total knee arthroplasty (TKA), total hip arthroplasty (THA) or hip resurfacing (HR) with XPERIENCE™ (XP) Advanced Surgical Irrigation versus dilute Betadine (DB).A teljes eredeti leírásKevesebb

Evaluating XPERIENCE™ Advanced Surgical Irrigation on Risk of Periprosthetic Joint Infection: A Multicenter Randomized Controlled Trial

A prospective, multi-center, double-arm, parallel, interventional, randomized, controlled clinical trial to assess the rate of periprosthetic joint infection (PJI) in patients undergoing primary total knee arthroplasty (TKA), total hip arthroplasty (THA) or hip resurfacing (HR) with XPERIENCE™ (XP) Advanced Surgical Irrigation versus dilute Betadine (DB).

Bevonási feltételek: Male and female patients aged 18 years or older; Diagnosis of osteoarthritis, inflammatory arthritis, osteonecrosis, or post-traumatic arthritis to the affected joint; Primary TKA, THA, and HR; Subjects receiving both cemented or uncemented orthopaedic implants; Willing and able to sign written consent, follow study protocol and attend follow-up.

Kizáró feltételek: Prior arthroplasty procedure to the affected joint; Procedures involving solid HA implants; Allergy to any of the components of XP Advanced Surgical Irrigation; Allergy to iodine; History of septic arthritis to the affected joint within two years of surgery(1); History of steroid injection to the affected joint within the three months preceding surgery; Presence of concurrent active infection, primary immunodeficiency, history of uncontrolled HIV (CD4 count <200 cells/uL), treatment with immunomodulatory medications for malignancy or autoimmune disease (with exception to inflammatory arthritis), chronic glucocorticosteroid use (≥20 mg of prednisone daily for at least 1 month with another cause of immunosuppression), and solid organ and/or bone marrow transplantation; Inability or refusal to sign informed consent form; Non-English or French speaking, and no licensed translator, family member or substitute decision maker available; Oncologic diagnosis to the affected joint; Non-TKA, THA or HR prosthesis (i.e., hemiarthroplasty, unicompartmental arthroplasty etc.); Simultaneous bilateral total joint arthroplasty.

ClinicalTrials.gov NCT05543941